| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |